Banque Cantonale Vaudoise’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.87M | Buy |
5,743
+2,015
| +54% | +$657K | 0.08% | 247 |
|
|
2025
Q1 | $1.01M | Buy |
+3,728
| New | +$1.01M | 0.04% | 354 |
|
|
2024
Q3 | $1.53M | Buy |
+5,560
| New | +$1.53M | 0.06% | 269 |
|
|
2023
Q4 | – | Sell |
-2,058
| Closed | -$365K | – | 1012 |
|
|
2023
Q3 | $365K | Sell |
2,058
-2,842
| -58% | -$504K | 0.02% | 545 |
|
|
2023
Q2 | $931K | Buy |
4,900
+2,100
| +75% | +$399K | 0.04% | 361 |
|
|
2023
Q1 | $561K | Hold |
2,800
| – | – | 0.03% | 427 |
|
|
2022
Q4 | $666K | Sell |
2,800
-3,500
| -56% | -$833K | 0.03% | 389 |
|
|
2022
Q3 | $1.26M | Buy |
6,300
+3,500
| +125% | +$701K | 0.07% | 268 |
|
|
2022
Q2 | $408K | Hold |
2,800
| – | – | 0.02% | 545 |
|
|
2022
Q1 | $458K | Hold |
2,800
| – | – | 0.02% | 582 |
|
|
2021
Q4 | $475K | Sell |
2,800
-300
| -10% | -$50.9K | 0.02% | 595 |
|
|
2021
Q3 | $585K | Hold |
3,100
| – | – | 0.03% | 524 |
|
|
2021
Q2 | $526K | Hold |
3,100
| – | – | 0.02% | 579 |
|
|
2021
Q1 | $438K | Buy |
3,100
+1,700
| +121% | +$240K | 0.02% | 572 |
|
|
2020
Q4 | $182K | Sell |
1,400
-2,400
| -63% | -$312K | 0.01% | 743 |
|
|
2020
Q3 | $553K | Buy |
3,800
+1,001
| +36% | +$146K | 0.04% | 404 |
|
|
2020
Q2 | $414K | Buy |
2,799
+299
| +12% | +$44.2K | 0.03% | 439 |
|
|
2020
Q1 | $272K | Hold |
2,500
| – | – | 0.02% | 539 |
|
|
2019
Q4 | $288K | Buy |
+2,500
| New | +$288K | 0.02% | 626 |
|